What's even more impressive is that genetically modified mice that could
not produce the aP2 protein are
supermice. We cannot make them obese, diabetic or atherosclerotic. They
don't develop fatty liver disease, and they don't develop asthma.
So now I'm just waiting for gene therapy to become a practical reality so I can get rid of my twice daily inhaled doses of 200 µg of glucocorticosteroid against my asthma. That, or wait for the aP2 blocking drugs to get to the market, and since they're only in the pre-clinical stage now, it probably means I'll have to wait 10–12 years before I can get a prescription for it.
Advances in drugs are too slow if you ask me.